Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial.

Toru AraiHiroshi KidaYoshitaka OgataSatoshi MarumoHiroto MatsuokaIwao GohmaSuguru YamamotoMasahide MoriChikatoshi SugimotoKazunobu TachibanaMasanori AkiraYoshikazu Inoue

Published in: BMJ open respiratory research (2021)

Treatment with rhTM might improve survival in AE-IIP cases with poor prognoses.Trial registration numberUMIN000014969, date: 28 August 2014.

Keyphrases

respiratory failure
phase iii
study protocol
phase ii
clinical trial
liver failure
randomized controlled trial
open label
extracorporeal membrane oxygenation
aortic dissection
cell free
placebo controlled
replacement therapy